Overview of SGPT Levels in Type 2 Diabetes Mellitus Patients at Idaman Banjarbaru Hospital 2026

Authors

  • Anggita Eka Ardenia Ardenia Universitas Borneo Lestari, Kalimantan Selatan
  • Muhammad Arsyad Universitas Borneo Lestari, Kalimantan Selatan
  • Nurul Amalia Universitas Borneo Lestari, Kalimantan Selatan

Keywords:

Type 2 Diabetes Mellitus, Liver Function, SGPT

Abstract

Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disease characterized by hyperglycemia resulting from impaired insulin secretion and insulin resistance. Chronic hyperglycemia may increase the risk of various complications, including liver dysfunction, which can be indicated by elevated levels of Serum Glutamic Pyruvic Transaminase (SGPT). SGPT examination serves as an indicator of hepatocellular injury and is therefore important in the evaluation of patients with T2DM. This study aimed to describe SGPT levels in patients with Type 2 Diabetes Mellitus at RSD Idaman Banjarbaru. This research employed a retrospective descriptive study. A total of 54 patients with Type 2 Diabetes Mellitus were included as the study sample using an accidental sampling technique. Data were obtained from laboratory examination results, medical records, and questionnaires. SGPT levels were measured using the BioSystems BA-200 analyzer with the enzymatic kinetic method. Data were analyzed using univariate analysis and presented as frequency distributions, percentages, mean values, minimum values, and maximum values. The results showed that most respondents were female, accounting for 30 patients (55.6%), and belonged to the 55–64 years age group, comprising 21 patients (38.9%). A total of 49 respondents (90.7%) had normal SGPT levels, while 5 respondents (9.3%) had elevated SGPT levels. In conclusion, the majority of patients with Type 2 Diabetes Mellitus at RSD Idaman Banjarbaru had SGPT levels within the normal range. However, regular monitoring of liver function remains essential for the early detection of liver dysfunction.

References

American Diabetes Association. (2024). Comprehensive Medical Evaluation and Assessment of Comorbidities : Standards of Care in Diabetes — 2024. 47(January), 52–76. https://doi.org/https://doi.org/10.2337/dc24-S004

Astiti, M. Y. D., Herawati, S., & Subawa, A. A. N. (2021). Umur Dan Jenis Kelamin Sebagai Faktor Risiko Peningkatan Kadar Serum Glutamik-Piruvic Transaminase ( SGPT ) Pada Pasien Diabetes Melitus Tipe 2 Di Rumah Sakit Umum Pusat Sanglah. Jurnal Medika Udayana, 10(9), 78–81. https://doi.org/doi:10.24843.MU.2020.V10.i9.P13 78

Bar-tana, J. (2021). Insulin Resistance , Secretion and Clearance – Taming the Three Effector Encounter of Type 2 Diabetes. 12(September), 10–13. https://doi.org/10.3389/fendo.2021.741114

Boeriu, A., Dobru, D., & Fofiu, C. (2023). Non-Invasive Diagnostic of NAFLD in Type 2 Diabetes Mellitus and Risk Stratification : Strengths and Limitations. 1–24. https://doi.org/. https://doi.org/10.3390/life13122262

Ginting, D. O., Angie, E., & Natali, O. (2024). Gambaran fungsi Hati Pada Pasien Diabetes Melitus Tipe 2 di RSU Royal Prima Medan Tahun 2022. Jurnal Kesehatan Tambusai, 5(1), 2025–2031.

Hartini, S., Khusnul Khotimah, C., & Kusumawati, N. (2024). Gambaran Faal Hati Pada Penderita Diabetes Mellitus Nilai SGOT dan SGPT. Journal Health & Science : Gorontalo Journal Health and Science Community, 16, 25–33. https://ejurnal.ung.ac.id/index.php/gojhes/index

Hasanuddin, A., Thahir, S., & Hardianti, D. (2019). Gambaran Kadar Serum Glutamate Oxalocetic Transminase (SGOT) dan Glutamate Pyruvat Transminase (SGPT) pada Pasien Diabetes Melitus di RSUD Syekh Yusup Kab. Gowa. Jurnal Media Laboran, 9(2), 23–28.

Hura, P. R. (2024). Hubungan Kadar SGOT dan SGPT Pada Penderita Diabetes Mellitus di Puskesmas Hibala Tahun 2024.

Johnson, J. D. (2021). On the causal relationships between hyperinsulinaemia , insulin resistance , obesity and dysglycaemia in type 2 diabetes. 2138–2146.

Lee, S., Park, S., & Choi, C. S. (2022). Insulin Resistance : From Mechanisms to Therapeutic Strategies. Diabetes & Metabolism Journal, 15–37. https://doi.org/https://doi.org/10.4093/dmj.2021.0280

Maulana, M. R., & Kuswarini, S. (2022a). Analisis Risiko Kadar Enzim SGOT dan SGPT pada Penderita Diabetes Mellitus Tipe 2. Jurnal Laboratorium Medis, 04(01), 51–55.

Maulana, M. R., & Kuswarini, S. (2022b). Analisis Risiko Kadar Enzim SGOT dan SGPT pada Penderita Diabetes Mellitus Tipe 2 Risk Analysis of AST and ALT level in Patients with Diabetes Mellitus Type 2 MOCHAMAD RIZAL MAULANA SUTJI KUSWARINI Universitas Airlangga Abstrak Kata Kunci : Diabetes Melli. Jurnal Laboratorium Medis, 04(01), 51–55.

Paknianiwewan, M. O., Triandhini, R. L. N. . R., & Mangalik, G. (2021). Pola Makan dan Aktivitas Fisik Penderita Diabetes Melitus Tipe II di RSUD Kota Salatiga. Jurnal Keperawatan Muhammadiyah, 6(2).

Shaw, J. E., & Magliano, D. J. (2022). The burden and risks of emerging complications of diabetes mellitus. Dunya Tomic Jonathan E. Shaw Dianna J. Magliano, 18(September). https://doi.org/10.1038/s41574-022-00690-7

Soebagijo et al. (2019). Pengelolaan Dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia 2019. In PB Perkeni.

Strati, M., Moustaki, M., Psaltopoulou, T., Vryonidou, A., & Paschou, S. A. (2024). Early onset type 2 diabetes mellitus : an update. Endocrine, 965–978. https://doi.org/10.1007/s12020-024-03772-w

Tanjung, D. I. U., Razoki, Karo, R. M. B., & Neswita, E. (2022). Pengaruh Konseling Obat Terhadap Kepatuhan Pasien Diabetes Melitus Tipe 2 Di Apotek Reza Farma. Journal Health and Science ; Gorontalo Journal Health & Science Community, 6(2), 213. https://ejurnal.ung.ac.id/index.php/gojhes/index

Tiurma, J. R., & Syahrizal. (2021). Obesitas Sentral dengan Kejadian Hiperglikemia pada Pegawai Satuan Kerja Perangkat Daerah. Higeia Journal Of Publc Health Research And Development, 5(3), 354–364.

Wardhana, K. W., & Rahman, S. (2025). Peningkatan Pengetahuan Lansia Tentang Diabetes Melitus Melalui Edukasi Pada Kegiatan KKN. Jurnal Ilmu Kesehatan, 21(1), 1–7. https://doi.org/10.5455/mnj.v1i2.644xa

Zhao, H., Song, X., Li, Z., & Wang, X. (2018). Risk factors associated with nonalcohol fatty liver disease and fibrosis among patients with type 2 diabetes mellitus. Medicine (United States), 97(37), 1–5. https://doi.org/10.1097/MD.0000000000012356

Downloads

Published

2026-08-29

How to Cite

Ardenia, A. E. A., Arsyad, M., & Amalia, N. (2026). Overview of SGPT Levels in Type 2 Diabetes Mellitus Patients at Idaman Banjarbaru Hospital 2026. JURNAL KESEHATAN, SAINS, DAN TEKNOLOGI (JAKASAKTI), 5(2), 617–623. Retrieved from https://jurnal.undhirabali.ac.id/index.php/jakasakti/article/view/5802

Issue

Vol. 5 No. 2 (2026): JURNAL KESEHATAN, SAINS, DAN TEKNOLOGI (JAKASAKTI)

Section

Articles

License

Copyright (c) 2026 JURNAL KESEHATAN, SAINS, DAN TEKNOLOGI (JAKASAKTI)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.


This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.